G6PD and non-autoimmune hemolytic anemia: In multicentre clinical trials in G6PD-normal patients, chloroquine plus tafenoquine reduced the 6-month incidence of P vivax malaria recurrence by 70% (95% CI 60–78) compared with chloroquine plus placebo,11 with no occurrences of drug-induced acute haemolytic anaemia.12